| Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection AJ Gonzales-Luna, AO Olaitan, WJ Shen, A Deshpande, TJ Carlson, ... Open forum infectious diseases 8 (8), ofab365, 2021 | 23 | 2021 |
| PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255 AJ Gonzales-Luna, TJ Carlson, KM Dotson, K Poblete, G Costa, ... Emerging Microbes & Infections 9 (1), 341-347, 2020 | 22 | 2020 |
| Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing BT Endres, KM Dotson, K Poblete, J McPherson, C Lancaster, E Bassères, ... Infection Control & Hospital Epidemiology 39 (11), 1322-1329, 2018 | 18 | 2018 |
| Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial KW Garey, J McPherson, AQ Dinh, C Hu, J Jo, W Wang, CK Lancaster, ... Clinical Infectious Diseases 75 (7), 1164-1170, 2022 | 17 | 2022 |
| A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome … KW Garey, K Begum, C Lancaster, A Gonzales-Luna, D Bui, J Mercier, ... Journal of Antimicrobial Chemotherapy 75 (12), 3635-3643, 2020 | 17 | 2020 |
| Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection TJ Carlson, BT Endres, J Le Pham, AJ Gonzales-Luna, FS Alnezary, ... Open forum infectious diseases 7 (1), ofz552, 2020 | 16 | 2020 |
| Epidemic Clostridioides difficile Ribotype 027 Lineages: Comparisons of Texas Versus Worldwide Strains BT Endres, K Begum, H Sun, ST Walk, A Memariani, C Lancaster, ... Open forum infectious diseases 6 (2), ofz013, 2019 | 16 | 2019 |
| In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile K Begum, E Bassères, J Miranda, C Lancaster, AJ Gonzales-Luna, ... Antimicrobial Agents and Chemotherapy 64 (8), 10.1128/aac. 00522-20, 2020 | 13 | 2020 |
| Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection TJ Carlson, AJ Gonzales-Luna, K Nebo, HY Chan, NLT Tran, S Antony, ... Open Forum Infectious Diseases 7 (11), ofaa476, 2020 | 8 | 2020 |
| In vitro activity of eravacycline against common ribotypes of Clostridioides difficile E Basseres, K Begum, C Lancaster, AJ Gonzales-Luna, TJ Carlson, ... Journal of Antimicrobial Chemotherapy 75 (10), 2879-2884, 2020 | 8 | 2020 |
| Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation AJ Gonzales-Luna, JK Spinler, N Oezguen, MAW Khan, HA Danhof, ... Anaerobe 70, 102387, 2021 | 7 | 2021 |
| Functional and metagenomic evaluation of ibezapolstat for early evaluation of anti-recurrence effects in Clostridioides difficile infection J McPherson, C Hu, K Begum, W Wang, C Lancaster, AJ Gonzales-Luna, ... Antimicrobial Agents and Chemotherapy 66 (8), e02244-21, 2022 | 6 | 2022 |
| Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings J Jo, AJ Gonzales-Luna, CK Lancaster, JK McPherson, K Begum, ... Anaerobe 75, 102543, 2022 | 4 | 2022 |
| Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh AK Sofjan, MA Islam, K Halder, ND Kabir, AA Saleh, J Miranda, ... Anaerobe 61, 102081, 2020 | 3 | 2020 |
| Fusobacteria behaving badly: Masquerading strains of strictly anaerobic Escherichia coli misidentified due to the deletion of the hemB gene BT Endres, E Basseres, DM Citron, KL Tyrrell, K Begum, C Lancaster, ... Anaerobe 79, 102682, 2023 | 2 | 2023 |
| 1669. A US Based National Surveillance Study for the Susceptibility and Epidemiology of Clostridioides difficile Associated Diarrheal Isolates with Special … LA McDermott, CM Thorpe, E Goldstein, A Schuetz, S Johnson, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1299, 2022 | 1 | 2022 |
| 489. Bile Acid Concentrations in Healthy Volunteers Receiving Oral Omadacycline or Vancomycin J Jo, C Hu, W Wang, AJ Gonzales-Luna, C Lancaster, KW Garey Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 547, 2022 | 1 | 2022 |
| Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centers CP Schroeder, RL Hengel, RV Nathan, TE Ritter, EN Obi, C Lancaster, ... Anaerobe 77, 102617, 2022 | 1 | 2022 |
| 710. Increased Clinical Failure Rates Associated with Reduced Metronidazole Susceptibility in Clostridioides difficile A Gonzales-Luna, WJ Shen, K Dotson, C Lancaster, B Endres, F Hossain, ... Open Forum Infectious Diseases 5 (Suppl 1), S255, 2018 | 1 | 2018 |
| Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile E Bassères, TA Eubank, K Begum, MJ Alam, J Jo, TM Le, CK Lancaster, ... Antimicrobial Agents and Chemotherapy, e01621-23, 2024 | | 2024 |
